✦ LIBER ✦

Coexpression of HER-2/neuand p53 is associated with a shorter disease-free survival in node-positive breast cancer patients

✍ Scribed by C. Wiltschke; I. Kindas-Muegge; A. Steininger; A. Reiner; G. Reiner; P. N. Preis

Book ID: 112496248
Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 656 KB
Volume: 120
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf01194273

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevation of the serum HER2/neu level is

Elevation of the serum HER2/neu level is associated with shorter progression-free survival after chemotherapy in metastatic breast cancer

✍ D. Lueftner; C. Akrivakis; P. Henschke; B. Flath; R. Geppert; K. Wernecke; K. Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Association of a common genetic variant

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer

✍ Muendlein, Axel; Lang, Alois H.; Geller-Rhomberg, Simone; Winder, Thomas; Gasser 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 231 KB

Overexpression of CXCR4 in Primary Tumor

Overexpression of CXCR4 in Primary Tumor of Patients with HER-2 Negative Breast Cancer was Predictive of a Poor Disease-Free Survival: A Validation Study

✍ Jason Mizell; Mark Smith; Benjamin D. L. Li; Fred Ampil; Quyen D. Chu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 283 KB

Prognostic value of the quantitative mea

Prognostic value of the quantitative measurement of the oncoprotein p185Her-2/neu in a group of patients with breast cancer and positive node involvement

✍ Uriel Bohn; José Aguiar; Cristina Bilbao; Adolfo Murias; Victor Vega; Ricardo Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

## Abstract Our study attempts to determine the prognostic value of the quantitative measurement of the oncoprotein p185^Her‐2/neu^ in a group of patients with breast cancer and positive node involvement. In a series of 217 patients with breast cancer and positive nodes in whom the oncoprotein p185

P69 Long term impact on disease-free sur

P69 Long term impact on disease-free survival (DFS) andoverall survival (OS) of adjuvant anthracycline (AA) based chemotherapy (CT) in node positive (N+) breast cancer patients (PTS): A report of 258 pts with 20 years (Y) of follow-up (FU)

✍ H. Auvray; J. Ferriere; C. Molucon; J. Dauplat; J. Achard; F. Kwiatkowski; P. Ch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

The effect of body mass index on overall

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

✍ Evandro de Azambuja; Worta McCaskill-Stevens; Prudence Francis; Emmanuel Quinaux 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 307 KB